Society Past-President Andrea Dunaif Named Division Chief at Mount Sinai


Endocrine Society past-president, Andrea Dunaif, MD, has been appointed the new Chief for the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes, and Bone Disease for the Mount Sinai Health System. She replaces Society member Derek Leroith, MD, PhD, who served as interim chief for the last year.

Dunaif, who served as the Endocrine Society president from 2005 to 2006, will build on Mount Sinai’s research on diabetes, metabolism, and endocrine disorders. Dunaif also plans to expand Mount Sinai’s comprehensive clinical services for patients with diabetes and other endocrine disorders, including its artificial pancreas program.

“Dr. Dunaif is an exceptional physician and researcher in the field of diabetes and women’s health,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “We look forward to her help in building on our long and distinguished tradition of excellence in research and education in the field of endocrinology, diabetes and bone disease.”

Dunaif comes to Mount Sinai from Northwestern University’s Feinberg School of Medicine, in Chicago, where she is the Charles F. Kettering Professor of Endocrinology and Metabolism and was the Chief of the Division of Endocrinology, Metabolism, and Molecular Medicine for 10 years. Prior to joining Northwestern, she held a number of leadership positions in academic medicine, including Chief of the Division of Women’s Health at Brigham and Women’s Hospital in Boston, Director of Harvard Medical School’s Center of Excellence in Woman’s Health, and Director of the Center for Clinical Research at Northwestern.

“Dr. Dunaif is a world-renowned endocrinologist with clinical and research expertise on diabetes and polycystic ovary syndrome (PCOS). I look forward to working with her as she transforms the management of our patients with diabetes and brings cutting-edge, transformational research in PCOS and women’s health to Mount Sinai,” said Barbara Murphy, MD, System Chair, Department of Medicine, Mount Sinai Health System, and Murray M. Rosenberg Professor of Medicine, Icahn School of Medicine at Mount Sinai.

Dunaif is leading an international effort to map the genes for PCOS, a leading cause of diabetes in women. She will continue this important research and other work in diabetes and insulin resistance at Mount Sinai.

“I’m very excited to return to Mount Sinai, where I began my academic career in 1982 as an Instructor in the Departments of Medicine and Obstetrics and Gynecology,” Dunaif says. “I look forward to working with the outstanding faculty at Mount Sinai and to collaborating closely with the scientists in the Mount Sinai Diabetes, Obesity, and Metabolism Institute.”

Dunaif has been continuously funded by the National Institutes of Health as a principal investigator for more than 30 years. She has received a multitude of awards and honors, including election to the American Society for Clinical Investigation and the Association of American Physicians. She is a member of numerous advisory and editorial boards and committees.

She received her medical degree from Columbia University College of Physicians and Surgeons and completed her internship and residency training at Presbyterian Hospital. She completed a clinical and research fellowship in endocrinology at Massachusetts General Hospital, where she also did a clinical and research fellowship in medicine and gynecology. She holds an honorary Doctor Honoris Causa from the University of Athens Medical School.

You may also like

  • Global Leadership Academy Launches at ENDO 2017

    When researchers and clinicians get to a certain stage in their careers, often their momentum can grow somewhat stagnant. Their education and much of their training is already behind them so the future can be somewhat uncertain. At this stage in many careers, it is time to assume a leadership role. However, for endocrinology professionals,…

  • Endocrine Society Response to Immigration Order

    President Donald Trump signed an executive order on Friday, January 27, limiting refugees into the U.S., barring the citizens of seven countries – Iraq, Iran, Syria, Somalia, Sudan, Libya, and Yemen – from entering the U.S. on any visa category, and, consequently, also creating new barriers to the global exchange of scientific information. The order…

Find more in